|
- 2017
Systemic BRAF/MEK Inhibitors as a Potential Treatment Option in Metastatic Conjunctival MelanomaDOI: 10.1159/000452473 Keywords: Conjunctival melanoma, BRAF inhibitor, MEK inhibitor, Primary acquired melanosis, Metastatic disease Abstract: In this review, we outline similarities between conjunctival and skin melanoma as well as the effectiveness of combined BRAF/MEK inhibition in melanoma, and discuss the applicability of these agents in conjunctival melanoma
|